Europe's rare disease innovation progress at risk, warns senior Chiesi executive

EURACTIV - In this Euractiv interview, Enrico Piccinini, Senior Vice President, EU & International, Rare Diseases at Chiesi, calls for a comprehensive overhaul of the EU's approach to rare disease research, advocating for a more integrated ecosystem that nurtures early-stage scientific discovery, enhances patient access, and ensures sustained investment in ultra-rare therapies. Read more

"Many rare diseases have a neurological component, and current treatments can't reach the brain. If we can overcome that, it would be a complete breakthrough." [Getty Images: TEK IMAGE/SCIENCE PHOTO LIBRARY]